NDC 73554-3111 – Zynteglo

Betibeglogene Autotemcel 20000000 1/1 · Suspension · Intravenous

Cellular Therapy

Product NDC73554-3111

Product details

Brand name
Zynteglo
Generic name
Betibeglogene autotemcel
Labeler
Genetix Biotherapeutics Inc.
Dosage form
Suspension
Route
Intravenous
Marketing category
BLA · BLA125717
Marketed since
August 17, 2022
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Zynteglo →

Package NDC codes (1)

Package NDCDescriptionSince
73554-3111-11 SUSPENSION in 1 BAG (73554-3111-1)Aug 17, 2022